Franklin Genomic Advancements ETF Forecast
Franklin Genomic Advancements ETF price ended at $31.31 on Tuesday, after gaining 0.83%.
(Updated on May 07, 2024)
The Franklin Genomic Advancements ETF price gained 0.83% on the last trading day (Tuesday, 7th May 2024), rising from $31.05 to $31.31. It has now gained 5 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the last trading day the ETF fluctuated 0% from a day low at $31.31 to a day high of $31.31. The price has risen in 6 of the last 10 days and is up by 1.95% over the past 2 weeks. Volume fell on the last day by -1 thousand shares and in total, 2 thousand shares were bought and sold for approximately $50.50 thousand. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.
The ETF lies in the middle of a wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the ETF is expected to fall -3.61% during the next 3 months and, with a 90% probability hold a price between $28.04 and $31.16 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
HELX Signals & Forecast
A buy signal was issued from a pivot bottom point on Friday, April 19, 2024, and so far it has risen 6.77%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Franklin Genomic Advancements ETF holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the ETF giving a more negative forecast for the stock. On further gains, the ETF will meet resistance from the long-term Moving Average at $31.42. On a fall, the ETF will find some support from the short-term average at $30.70. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may not be. The very low volume increases the risk and reduces the other technical signals issued.
Support, Risk & Stop-loss for Franklin Genomic Advancements ETF
Franklin Genomic Advancements finds support from accumulated volume at $31.17 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
In general the ETF tends to have controlled movements and therefore the general risk is considered low. However, be aware of low or falling volume and make sure to keep an eye on the ETF. During the last day, the ETF moved $0 between high and low, or 0%. For the last week the ETF has had daily average volatility of 0.317%.
Our recommended stop-loss: $30.00 (-4.18%) (This ETF has low daily movements and this gives low risk. There is a buy signal from a pivot bottom found 12 days ago.)
Trading Expectations (HELX) For The Upcoming Trading Day Of Wednesday 8th
For the upcoming trading day on Wednesday, 8th we expect Franklin Genomic Advancements ETF to open at $31.31, and during the day (based on 14 day Average True Range), to move between $31.01 and $31.61, which gives a possible trading interval of +/-$0.301 (+/-0.96%) up or down from last closing price. If Franklin Genomic Advancements ETF takes out the full calculated possible swing range there will be an estimated 1.92% move between the lowest and the highest trading price during the day.
Since the stock is closer to the support from accumulated volume at $31.17 (0.46%) than the resistance at $32.56 (3.98%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..
Is Franklin Genomic Advancements ETF ETF A Buy?
Franklin Genomic Advancements holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.
Current score: 0.999 Hold/Accumulate Unchanged
Predicted Opening Price for Franklin Genomic Advancements ETF of Wednesday, May 8, 2024
| Fair opening price May 8, 2024 | Current price |
|---|---|
| $31.31 ( 0%) | $31.31 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for HELX
Fibonacci Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 31.31 | . | |
| R2 | 31.31 | . | ||
| R1 | 31.31 | . | ||
| Current price: | 31.31 | |||
| Support | S1 | 31.31 | . | |
| S2 | 31.31 | . | ||
| S3 | 31.31 | . |
Accumulated Volume Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 32.74 | 4.58 % | |
| R2 | 32.58 | 4.06 % | ||
| R1 | 32.56 | 3.98 % | ||
| Current price | 31.31 | |||
| Support | S1 | 31.17 | -0.460% | |
| S2 | 31.05 | -0.83% | ||
| S3 | 30.18 | -3.61% |
HELX Dividend Payout History
| # | Ex-Date | Pay Date | Amount | Yield | |
|---|---|---|---|---|---|
| 1 | Dec 29, 2021 | Dec 30, 2021 | Jan 07, 2022 | $0.0040 | 0.0094% |
| 2 | Dec 10, 2021 | Dec 13, 2021 | Dec 21, 2021 | $0.114 | 0.238% |
| 3 | Dec 11, 2020 | Dec 14, 2020 | Dec 23, 2020 | $0.0520 | 0.111% |
FAQ
Click here for our free guide on how to buy Franklin Genomic Advancements ETF ETF.
